Testing paradox may explain increased observed prevalence of bacterial STIs among MSM on HIV PrEP: A modeling study

L Laura Müller (Max Planck Institute for Dynamics and Self-Organization) P Piklu Mallick (Max Planck Institute for Dynamics and Self-Organization) A Antonio B. Marín-Carballo (Max Planck Institute for Dynamics and Self-Organization) P Philipp Dönges (Max Planck Institute for Dynamics and Self-Organization) R Robyn J. N. Kettlitz (Department of Epidemiology) C Carolina J. Klett-Tammen (Department of Epidemiology) M Mirjam Kretzschmar (University Medical Center Utrecht) V Viola Priesemann (Max Planck Institute for Dynamics and Self-Organization) S Seba Contreras (Max Planck Institute for Dynamics and Self-Organization)

Abstract

HIV pre-exposure prophylaxis (PrEP) is transforming global HIV prevention, but its implementation coincides with observations of rising bacterial sexually transmitted infection (STI) rates among men who have sex with men, raising questions about whether PrEP is preventing one epidemic while facilitating others. To reconcile this apparent contradiction, we developed a minimal dynamical model of the simultaneous transmission of HIV and chlamydia (as an example of a curable STI). The model integrates three key mechanisms: 1) risk-mediated self-protective behavior, 2) reduction in condom use among PrEP users, and 3) PrEP-related asymptomatic STI screening. We show that these mechanisms can generate a “testing paradox:” True STI prevalence may decline while observed trends rise. This paradox emerges because increased PrEP uptake amplifies screening intensity, which can lower transmission but simultaneously inflate detection. By systematically mapping the parameter space of PrEP uptake, screening frequency, and risk perception, we identify broad and plausible conditions under which the paradox arises. Our findings reconcile conflicting epidemiological evidence and remark that the net effect of PrEP on STI dynamics depends critically on asymptomatic screening strategies. These results highlight the potential dual role of PrEP programs in reducing both HIV and bacterial STI incidence, while emphasizing the need to align screening and treatment policies to maximize benefits and minimize risks, e.g., antimicrobial resistance.

Article Details

Volume / Issue Vol. 122, Issue 44
Published November 04, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

L

Laura Müller

Max Planck Institute for Dynamics and Self-Organization

P

Piklu Mallick

Max Planck Institute for Dynamics and Self-Organization

A

Antonio B. Marín-Carballo

Max Planck Institute for Dynamics and Self-Organization

P

Philipp Dönges

Max Planck Institute for Dynamics and Self-Organization

R

Robyn J. N. Kettlitz

Department of Epidemiology

C

Carolina J. Klett-Tammen

Department of Epidemiology

M

Mirjam Kretzschmar

University Medical Center Utrecht

V

Viola Priesemann

Max Planck Institute for Dynamics and Self-Organization

S

Seba Contreras

Max Planck Institute for Dynamics and Self-Organization